SC
LXRX icon

Sessa Capital’s Lexicon Pharmaceuticals LXRX Stock Holding History

Sessa Capital’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.9M Buy
17,912,961
+14,912,961
+497% +$21.7M 0.51% 25
2025
Q4 		$3.45M Hold
3,000,000
– – 0.06% 29
2025
Q3 		$4.05M Hold
3,000,000
– – 0.1% 27
2025
Q2 		$2.84M Buy
+3,000,000
New +$1.94M 0.08% 25

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sessa Capital's LXRX Position: Q1 2026 in Review

Sessa Capital increased its Lexicon Pharmaceuticals (LXRX) stake by 497% in Q1 2026, buying an estimated $21.7M and bringing the position to 17,912,961 shares worth $27.9M. The position accounts for 0.51% of the portfolio, ranked #25.

Sessa Capital first reported a position in LXRX in Q2 2025 and has held it in 4 quarters since. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Sessa Capital held 17,912,961 shares of Lexicon Pharmaceuticals worth $27.9M as of Q1 2026.
  • Sessa Capital bought 14,912,961 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $21.7M.
  • Lexicon Pharmaceuticals made up 0.51% of Sessa Capital's portfolio in Q1 2026, its #25 holding.
  • Sessa Capital first reported a position in Lexicon Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Sessa Capital's 13F filing for Q1 2026, filed 15 May 2026.